Origin, rise and evolution of the pharmaceutical industry in the United States, between medical advances and the debate over its prices

The history and evolution of the United States pharmaceutical industry reflect a continuous tension between medical innovation and public debate over drug pricing. This dynamic highlights fundamental questions about whether the sector prioritizes corporate profits or societal welfare.

Historical perspectives, such as a 1950 statement by pharmaceutical executive George Merck asserting that medicine is for the people rather than for profits, remain a central reference point in contemporary discussions surrounding the industry's ethical responsibilities and economic impact.